Protein-truncating variants in ATRIP were observed among 13 of 8410 breast cancer cases and 3 of 8238 controls in these two datasets (OR = 3.69, 95% CI = 1.43–9.52, p = 0.007) [9]. Here, ATRIP is linked to breast carcinoma.